MICROPORT CARDIO.MEDTECH. (72X) — Tangible Net Worth Ratio
MICROPORT CARDIO.MEDTECH. (72X) has a Tangible Net Worth Ratio of 100.0% as of June 2025. This metric is calculated by deducting intangible assets (€0.00) from net assets (€2.22 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See 72X current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
MICROPORT CARDIO.MEDTECH. Tangible Net Worth Ratio (2021–2024)
This chart shows how MICROPORT CARDIO.MEDTECH.'s Tangible Net Worth Ratio has changed across 4 annual periods from 2021 to 2024. As of June 2025, the ratio stands at 100.0%, reflecting net assets of €2.22 Billion with intangible assets of €0.00 EUR. See defensive interval ratio of MICROPORT CARDIO.MEDTECH. to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for MICROPORT CARDIO.MEDTECH. (2021–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for MICROPORT CARDIO.MEDTECH. from 2021 to 2024, covering 4 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see 72X market cap.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 91.3% | €2.22 Billion | €192.28 Million | €2.68 Billion | ▼ -2.5 pp |
| 2023 | 93.8% | €2.33 Billion | €143.88 Million | €2.58 Billion | ▼ -0.2 pp |
| 2022 | 94.1% | €2.75 Billion | €163.12 Million | €3.00 Billion | ▲ +1.8 pp |
| 2021 | 92.3% | €3.10 Billion | €238.75 Million | €3.36 Billion | — |